Download Download this free, 150-page Pharmaceutical Serialization Playbook jam-packed with strategies for success and pitfalls to avoid. Learn more >>
Read More on:
Safety > Child resistance
Healthcare > Pharmaceutical
Closures > Closures for rigid containers
Article |
February 3, 2013
Send to Kindle
Send to KindleChild-resistant cap may malfunction, so Novartis issues recall
Novartis Consumer Health, Inc. is voluntarily recalling certain lots of Triaminic® Syrups and Theraflu Warming Relief® Syrups that were manufactured in the United States prior to December 31, 2011.
By
Novartis Consumer Health has decided to issue a voluntary recall to consumers, retail customers and wholesalers in the U.S. because the child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place.
Consumers with questions are encouraged to contact the Novartis Consumer Relationship Center at 1-866-553-6742 (available Monday-Saturday 8 a.m. to midnight Eastern Time).
According to witn.com, 2.3 million units of Traminic and Theraflu are under recall. One child has needed medical attention after getting into the package, three others took the medicine but were okay, and eight other kids opened the medicine but did not ingest it, says witn.com
E-BOOK SPECIAL REPORT
45 Best Package Designs
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs.
Comments(0)
Add new comment